Alexa B. Turke

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist, Belinda A. Waltman, Dora Dias‐Santagata et al. · Science Translational Medicine · 2011 · 3.6K citations · Full text

Medicine, Genetics, Oncology +17

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu et al. · Cancer Cell · 2010 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +16

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of <i>BRAF</i> -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke et al. · Cancer Discovery · 2012 · 1K citations · Full text

Medicine, Oncology, Pharmacology +17

MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors

Alexa B. Turke, Youngchul Song, Carlotta Costa et al. · Cancer Research · 2012 · 364 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways

S. Michael Rothenberg, Kyle Concannon, Sarah Cullen et al. · eLife · 2015 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17